Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe hypernatremia: survival without neurologic sequelae].

R R Borrego Domínguez1, A Imaz Roncero, J López-Herce Cid

  • 1Sección de Cuidados Intensivos Pediátricos. Hospital General Universitario Gregorio Marañón. Madrid. España.

Anales De Pediatria (Barcelona, Spain : 2003)
|April 12, 2003
PubMed
Summary

This study examines two cases of children with severe hypernatremia (very high blood sodium levels) who survived without neurological damage. Both patients had sodium levels above 200 mEq/l and were treated with either hemodiafiltration or intravenous fluids. Their sodium levels dropped rapidly, and they showed no lasting neurological issues despite experiencing seizures during treatment. The authors suggest that careful, rapid correction may be possible in some cases, but they emphasize that individualized treatment plans are essential. These findings challenge the assumption that extreme hypernatremia always leads to poor outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Recommendations on cardiopulmonary resuscitation in patients with suspected or confirmed SARS-CoV-2 infection (COVID-19). Executive summary].

Medicina intensiva·2020
Same author

Pediatric and neonatal transport in Spain, Portugal and Latin America.

Medicina intensiva·2016
Same author

[Non-invasive ventilation has changed clinical practice in bronchiolitis].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

[Evolution of non-invasive ventilation in acute bronchiolitis].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

[Cardiac tamponade following thrombolysis with low dose rt-PA].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

Morbimortality associated to acute kidney injury in patients admitted to pediatric intensive care units.

Medicina intensiva·2013

Area of Science:

  • Pediatric critical care medicine
  • Electrolyte disorders in clinical nephrology

Background:

Severe hypernatremia remains a rare but life-threatening condition. Prior research has shown that elevated sodium levels above 190 mEq/l are associated with high mortality and neurological damage. This gap motivated investigations into the mechanisms and outcomes of extreme cases. No prior work had resolved whether survival without neurological sequelae is possible. Established knowledge includes the role of water loss and sodium retention in pathogenesis. However, the long-term effects of rapid correction remain uncertain. This paper's contribution is a detailed analysis of two pediatric cases. These cases challenge assumptions about the inevitability of neurological impairment.

Purpose Of The Study:

The aim of the study was to investigate outcomes in children with extreme hypernatremia. The specific problem addressed is whether rapid correction can prevent neurological damage. Motivation stems from the high mortality and poor prognosis typically observed. The researchers sought to determine if survival without neurological sequelae is achievable. The study focuses on two pediatric cases with severe electrolyte disturbances. The goal was to understand the relationship between treatment speed and outcomes. By analyzing these rare cases, the authors aimed to provide insights into optimal management. Their findings may inform clinical approaches to similar patients.

Keywords:
Severe hypernatremia treatmentPediatric electrolyte disordersRapid sodium correctionNeurological outcomes in children

Frequently Asked Questions

The authors report two cases where children with extreme hypernatremia (>200 mEq/l) survived without neurological sequelae after rapid correction.

One patient received hemodiafiltration, while the other was treated with intravenous fluid therapy to correct sodium levels.

Sodium levels decreased by more than 10 mEq/l per hour in both cases, resolving within 36–48 hours.

Both patients had convulsive crises during treatment but showed no lasting neurological impairments afterward.

Related Experiment Videos

Main Methods:

The study involved a retrospective analysis of two pediatric cases. Both patients had severe hypernatremia exceeding 200 mEq/l. The first case involved a 7-year-old with renal failure undergoing dialysis. The second was a 3-year-old with pseudohypoaldosteronism and encephalopathy. Treatment approaches included hemodiafiltration and intravenous fluid therapy. The researchers monitored changes in sodium levels and neurological status. Data collection focused on the rate of correction and clinical outcomes. The study design relied on detailed medical records and follow-up assessments. Findings were interpreted in the context of existing literature on hypernatremia.

Main Results:

The first patient's sodium level dropped from 216 mEq/l to normal within 48 hours. The second patient's sodium decreased from 203 mEq/l to normal in 36 hours. Both patients experienced a convulsive crisis during treatment. No neurological deficits were observed in either case post-treatment. The rate of correction exceeded 10 mEq/l per hour in both instances. This finding contrasts with prior reports of neurological damage at similar levels. The authors propose that rapid correction may be safe in certain clinical settings. These results suggest that survival without sequelae is possible under specific conditions.

Conclusions:

The authors propose that children with extreme hypernatremia may survive without neurological sequelae. Their findings suggest that rapid correction is feasible in some cases. The study does not claim that rapid correction is universally safe. The authors emphasize the importance of progressive natremia reduction. They do not assert that all patients will benefit from similar treatment speeds. The study does not propose new clinical guidelines or drug targets. The authors suggest that individualized treatment plans are essential. Their conclusions are limited to the specific cases presented.

The authors suggest that rapid correction may be safe in certain clinical contexts, challenging assumptions about neurological risks.

The authors do not propose a new protocol but suggest that individualized treatment plans may allow safe correction in specific cases.